Department of Health and Human Services' logo Department of Health and Human Services

Public Health Service
Food and Drug Administration


Seattle District
Pacific Region
22201 23rd Drive SE
Bothell, WA 98021-4421
Telephone: 425-486-8788
FAX: 425-483-4996

June 2, 2004


In reply refer to Warning Letter SEA 04-33

Yon Tai Chung, Owner
Lotte International Trading, Inc.
240 East 4th Avenue
Anchorage, Alaska 99501


Dear Mr. Chung:

The Food and Drug Administration (FDA) conducted inspections of your facility located at 240 East 4th Avenue, Anchorage, Alaska, on September 24, 2003, and January 20, 2004. As part of these inspections, FDA investigators collected samples and labels for several of your products: Guyryongtang (for young girls), Guyryongtang (for young boys), Wild Sanghwang Mushroom extract (Phellinus igniarius), and Darin Nokyong.

These inspections reveal that your products are misbranded within the meaning of Section 403 of the Federal Food, Drug, and Cosmetic Act (the Act) due to deviations from the food labeling requirements set forth in Title 21 Code of Federal Regulations Part 101 (21 CFR 101). You can find this Act and the food labeling requirements through links in FDA’s homepage at

The specific violations for your products are listed below.

Guyryongtang (for young girls) and (for young boys)

Wild Sanghwang Mushroom (extract)

Darin Nokyong

Lastly, we note that the serving size and number of “Servings Per Container” in the “Nutrition Facts” panel of the Guyryongtang products, Wild Sanghwang Mushroom (Extract), and Darin Nokyong are not presented in a manner required by 21 CFR 101.9(b). Title 21 CFR 101.9(b)(2)(i) states that when discrete units, such as individual foil pouches, are contained in a multi-serving package, the number of servings per container must be expressed in terms of the number of units that constitute a serving (e.g. 2 pouches). In the absence of any information regarding the nature of these products, we are unable to determine the appropriate reference amount customarily consumed that must be used to establish the labeled serving size. However, based on the information on the labels we offer the following recommendations for these products:

Under the Act, any substance, the intended use of which results or may reasonably be expected to result, in its becoming a component or otherwise affecting the characteristics of any food such as a food extract or tea, must be used in accordance with a food additive regulation approving the substance for that use, unless the substance is the subject of a prior sanction for that use, or is generally recognized as safe (GRAS) among qualified experts for its intended use in foods, or is otherwise exempt from the food additive definition in Section 201(s) of the Act. A substance added to food that is not the subject of a prior sanction for that us, is not GRAS for its intended use, and is not used in accordance with a food additive regulation causes the substance and the food containing the substance to be adulterated under Section 402(a)(2)(C) of the Act (21 U.S.C. 342(a)(2)(C)). Such food cannot be legally marketed in the United States. As a food manufacturer, it is your responsibility to ensure that all of the ingredients used in your food are in compliance with FDA’s laws and regulations.

The above violations are not meant to be an all-inclusive list of deficiencies for your product. Other violations can subject these products to legal action. Moreover, it is your responsibility to assure that your products are labeled in compliance with the Act and regulations enforced by FDA.

We request that you take prompt action to correct these violations. Failure to promptly correct violations may result in enforcement actions without further notice. These actions include seizure and/or obtaining a court injunction against further marketing of your products.

Please respond in writing within fifteen (15) working days from your receipt of this letter. Your response should outline the specific things you are doing to correct these deviations. If you cannot complete all corrections before you respond, we expect you will explain the reason for your delay and state the time at which corrections will be completed.

Please send your reply to the Food and Drug Administration, Attention: Lisa M. Elrand, Compliance Officer, 22201 23rd Drive SE, Bothell, Washington 98021-4421. If you have questions regarding any issue in this letter, please contact Lisa Elrand, Compliance Officer, at (425) 483-4913 or via e-mail at


Charles M. Breen
District Director

This page was posted on November 25, 2004.

Links to Recommended Companies

  • Compare drug prices and save money at verified online pharmacies.
  • Evaluates the quality of dietary supplement and herbal products.
  • Discount prices, huge inventory, and superb customer service.
  • OnlyMyEmail: Award-winning anti-spam services.
  • 10 Types: Website design, development, and hosting with superb technical support.